Heterogeneity among patients with latent autoimmune diabetes in adults

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 971-974

  Maruyama, Taro ^a   Nakagawa, Terumichi ^b   Kasuga, Akira ^c   Murata, Mitsuru ^b  

^a Saitama Social Insurance Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO ELECTRIC POWER COMPANY   (Japan)

Author keywords

Glutamic acid decarboxylase autoantibody; Insulin dependency; Latent autoimmune diabetes in adults; Prediction; Slowly progressive insulin dependent diabetes mellitus; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN CLASS 2; PANCREAS ISLET CELL ANTIBODY;

ADULT; AGE; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; AGED; AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 80855147850     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1238     Document Type: Article

References (11)

1. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42(2): 359-362.
2. Kobayashi T. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM-the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 1994; 24(Suppl.): S95-S99.
3. Fourlanos S, Dotta F, Greenbaum CJ, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005; 48(11): 2206-2212.
4. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. J Autoimmun 1999; 12(2): 131-135.
5. Maruyama T, Tanaka S, Shimada A, et al. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab 2008; 93(6): 2115-2121.
6. Maruyama T, Shimada A, Kasuga A, et al. Analysis of MHC class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay. Diabetes Res Clin Pract 1994; 23(2): 77-84.
7. Genovese S, Bazzigaluppi E, Gonçalves D, et al. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 2006; 154(3): 441-447.
8. Radtke MA, Midthjell K, Nilsen TI, Grill V. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study. Diabetes Care 2009; 32(2): 245-250.
9. Buzzetti R, Di Pietro S, Giaccari A, et al., Non Insulin Requiring Autoimmune Diabetes Study Group. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 2007; 30(4): 932-938.
10. Kawasaki E, Nakamura K, Kuriya G, et al. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab 2010; 95(2): 707-713.
11. Murao S, Kondo S, Ohashi J, et al. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)-a 5-year follow-up of the Ehime study. Diabetes Res Clin Pract 2008; 80(1): 114-121.